What is ArriVent BioPharma, Inc. Common Stock (AVBP) stock price today?

ArriVent BioPharma, Inc. Common Stock (AVBP) currently trades at $24.89 per share. The stock has a market capitalization of $1.10B and a P/E ratio of —x.

Is AVBP stock a buy, sell, or hold in 2026?

Based on WallStSmart's proprietary analysis, ArriVent BioPharma, Inc. Common Stock has a Smart Value Score of 26/100 (Grade F), resulting in a "Strong Sell" investment rating. The Piotroski F-Score is 2/9 and Altman Z-Score is —.

Is ArriVent BioPharma, Inc. Common Stock financially healthy?

ArriVent BioPharma, Inc. Common Stock's Piotroski F-Score is 2/9 (weak financial health). The Altman Z-Score of — places it in the —.

AVBP

ArriVent BioPharma, Inc. Common Stock

NASDAQ: AVBP · HEALTHCARE · BIOTECHNOLOGY

$24.89

+2.77% today

Updated 2026-04-02

Market cap

$1.10B

P/E ratio

—

EPS (TTM)

$-4.32

Dividend yield

—

52W range

$15 – $27

Volume

0.5M

WallStSmart proprietary scores

out of 100

Grade: F

Strong Sell

Investment rating

4.3

Growth

7.3

Quality

B+

3.0

Profitability

5.0

Valuation

C+

2/9

Piotroski F-Score

Weak

—

Altman Z-Score

—

Industry rank

—

View all highly rated stocks (75+) →195 stocks currently score above 75

Price targets

Analyst target

$41.10

+65.13%

12-Month target

—

Intrinsic (DCF)

—

Margin of safety

—

0 Strong Buy11 Buy0 Hold0 Sell0 Strong Sell

Price chart

X-Ray snapshot

Strengths

+ Debt/equity 0.00x — low leverage

Risks

- Piotroski 2/9 — weak financial health

- Thin margins at 0.00%

- Negative free cash flow $-30.66M

Key financials

Revenue Net Income Free Cash Flow

Metric	2022	2023	2024	2025	TTM
Revenue	$0.00	$0.00	$0.00	$0.00	$0.00
Net income	$-36.91M	$-69.33M	$-80.49M	$-166.31M	$-35.54M
EPS	—	—	—	—	$-4.32
Free cash flow	$-43.63M	$-55.84M	$-70.21M	$-160.59M	$-30.66M
Profit margin	—	—	—	—	—

Peer comparison

Company	Mkt Cap	Score	Growth	Profit	Value	Quality	MoS	Rating
AVBP	$1.10B	26	4.3	3.0	5.0	7.3	—	Avoid
LLY	$854.31B	78	10.0	10.0	5.3	6.5	+12.74%	Strong Buy
JNJ	$585.70B	71	7.3	9.0	6.7	6.0	+52.92%	Strong Buy
ABBV	$380.25B	63	4.0	8.0	4.0	5.0	-1201.18%	Buy
AZN	$315.47B	64	6.7	8.0	6.0	5.0	+32.66%	Buy
MRK	$298.76B	59	4.0	9.5	4.0	4.8	-144.48%	Buy

Smart narrative

ArriVent BioPharma, Inc. Common Stock trades at $24.89. Our Smart Value Score of 26/100 indicates the stock is weak. The company scores 2/9 on the Piotroski F-Score.

Frequently asked questions

What is ArriVent BioPharma, Inc. Common Stock's stock price?

ArriVent BioPharma, Inc. Common Stock (AVBP) trades at $24.89.

Is ArriVent BioPharma, Inc. Common Stock overvalued?

Smart Value Score 26/100 (Grade F, Strong Sell).

What is the price target of ArriVent BioPharma, Inc. Common Stock (AVBP)?

The analyst target price is $41.10, representing +65.1% upside from the current price of $24.89.

Piotroski F-Score?

2/9 — weak financial health.

Company info

SectorHEALTHCARE

IndustryBIOTECHNOLOGY

CountryUSA

ExchangeNASDAQ

CurrencyUSD

arrivent.com

Quick metrics

P/S ratio—

ROE-58.90%

Beta1.00

50D MA$23.06

200D MA$21.14

Shares out0.04B

Float0.03B

Short ratio—

Avg volume0.5M

Performance

1 week+13.02%

1 month-8.81%

3 months+16.44%

YTD+20.38%

1 year—

3 years—

5 years—

Compare

AVBP vs LLY →AVBP vs JNJ →AVBP vs ABBV →Stock screener →